Abstract:OBJECTIVE:To explore the effects of sodium hydrosulfide (NaHS), a hydrogen sulphide (H(2)S) donor, on cardiac functions and structures in rats with chronic heart failure induced by volume overload and examine its influence on cardiac remodelling.METHODS:A total of 47 SD rats (120 - 140 g) were randomly divided into 5 groups:shunt group (n = 11), sham group (n = 8), shunt + NaHS group (n = 10), sham + NaHS group (n = 8) and shunt + phentolamine group (n = 10). The rat model of chronic heart failure was induced by abdominal aorta-inferior vena cava puncture. At Week 8 post-operation, hemodynamic parameters, microstructures and ultrastructures of myocardial tissues were analyzed. Extracellular collagen content in myocardial tissues was analyzed after Sirius red staining. Right ventricular hydroxyproline concentration was determined and compared.RESULTS:At Week 8 post-operation, compared with the sham operation and shunt + NaHS groups, the shunt group showed significantly increased right ventricular systolic pressure (RVSP) and right ventricular end diastolic pressure (RVEDP) (mm Hg: 35.2 ± 3.9 vs 21.4 ± 3.7 and 28.1 ± 2.7, 32 ± 5 vs 21 ± 4 and 26 ± 4, all P < 0.05, 1 mm Hg = 0.133 kPa). The RV peak rate of contraction and relaxation markedly decreased (RV ± dp/dt max) (mm Hg/s: 1528 ± 113 vs 2336 ± 185 and 1835 ± 132, 1331 ± 107 vs 2213 ± 212 and 1768 ± 116, all P < 0.05). It was found microscopically that myocardial fibers in the shunt group were irregularly arranged, partially cytolysis and infiltrated by inflammatory cells. Electron microscopy revealed that myocardial fibers thickened non-uniformly in the shunt group, some fiber mitochondria were highly swollen and contained vacuoles. And sarcoplasmic reticulum appeared slightly dilated. Polarized microscopy indicated that, collagen content (particularly type-I collagen) increased in the shunt group compared with the sham operation group. Additionally, compared with the shunt group, the shunt and NaHS treatment groups showed an amelioration of myocardial damage, an alleviation of myocardial fiber changes and a decrease in myocardial collagen content (particularly type-I collagen). Compared with the sham operation and shunt + NaHS groups, the shunt group displayed increased right ventricular hydroxyproline (mg×g(-1)·pro: 1.32 ± 0.25 vs 0.89 ± 0.18 and 0.83 ± 0.19, all P < 0.05).CONCLUSION:H(2)S may improve cardiac functions and ameliorate cardiac structures in rats with chronic heart failure probably through dilating the blood vessels and affecting the extracellular collagen metabolism.

Protective Effects of Hydroxysafflor Yellow A on Acute and Chronic Congestive Cardiac Failure Mediated by Reducing ET-1, NOS and Oxidative Stress in Rats.

Effect of Hydroxy Safflower Yellow A on Myocardial Apoptosis after Acute Myocardial Infarction in Rats

Effect of hydroxysafflor yellow A on the activity of astrocytes in cerebral ischemic/reperfusion in rats

Effects of Hydroxy Safflor Yellow A on Cardiac Function of Isolated Hearts

Hydrogen Sulfide Attenuates Cardiac Dysfunction in a Rat Model of Heart Failure: a Mechanism Through Cardiac Mitochondrial Protection

Inhibitory Effect of Hydroxysafflor Yellow A Against Rat Myocardial Mitochondrial Injury

Sodium Hydrosulfide Improves Cardiac Functions and Structures in Rats with Chronic Heart Failure

Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling

Protective effects of hydroxysafflor yellow an on high oxidized low density lipoprotein induced human coronary artery endothelial cells injuries

Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats

Hydroxysafflor Yellow A Attenuates Renal Ischemia- Reperfusion Injury in A Rat Model

Luhong Formula and Hydroxysafflor yellow A protect cardiomyocytes by inhibiting autophagy

Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats

The effects of hydroxysafflor yellow A on blood pressure and cardiac function.

Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.

Hydrogen-containing Saline Alleviates Pressure Overload-Induced Interstitial Fibrosis and Cardiac Dysfunction in Rats

Neuroprotective Effects Of Hydroxysafflor Yellow A: In Vivo And In Vitro Studies

Hydroxysafflor Yellow a Alleviates Acute Myocardial Ischemia/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1α/SLC7A11/GPX4 Signaling Pathway

QSYQ Attenuates Oxidative Stress and Apoptosis Induced Heart Remodeling Rats Through Different Subtypes of NADPH-Oxidase.

The activation of the HIF-1α-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia-reperfusion injury

Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke